Clinical Trials Browser

Phase EARLY_PHASE1 × Prostatic Neoplasms × Ipilimumab × Clear all

NCT02113657 2024-05-24

T-Cell Responses to Neoantigens Post Treatment With Ipilimumab in Men With Metastatic Castration-Resistant Prostate Cancer

Phase EARLY_PHASE1 Completed

Neoplasm Metastasis, Prostatic Neoplasms